Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
์ข
๋ชฉ ์ฝ๋ SRDX
ํ์ฌ ์ด๋ฆSurmodics Inc
์์ฅ์ผMar 04, 1998
CEOHance (Robert B)
์ง์ ์389
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃMar 04
์ฃผ์9924 West 74th Street
๋์EDEN PRAIRIE
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ55344
์ ํ19525007000
์น์ฌ์ดํธhttps://www.surmodics.com/
์ข
๋ชฉ ์ฝ๋ SRDX
์์ฅ์ผMar 04, 1998
CEOHance (Robert B)
์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.

๋ฐ์ดํฐ ์์